免疫系统
芳香烃受体
生物
癌变
先天免疫系统
肿瘤微环境
获得性免疫系统
先天性淋巴细胞
免疫学
信号转导
癌症研究
细胞生物学
癌症
转录因子
基因
遗传学
作者
Prashant Trikha,Dean A. Lee
标识
DOI:10.1016/j.bbcan.2019.188335
摘要
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcriptional factor (TF) that is a member of the Per-Arnt-Sim family of proteins. AhR regulates diverse processes, including malignant transformation, hematopoietic cell development, and fate determination of immune cell lineages. Moreover, AhR forms a crucial link between innate and adaptive arms of the immune system. Malignant cells frequently evolve multiple mechanisms for suppressing tumor-specific responses, including the induction of suppressive pathways involving AhR and its metabolic byproducts in the tumor microenvironment that promote immune evasion and tumor progression. Thus, interest is high in further defining the role of AhR in carcinogenesis and immune development and regulation, particularly regarding the therapeutic interventions that unleash immune responses to cancer cells. Here, we provide an overview of the role of AhR in the regulation of innate and adaptive immune response and discuss the implications of targeting this pathway to augment the immune response in cancer patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI